Antithrombin III for critically ill patients
Research output: Contribution to journal › Journal article › Research › peer-review
Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.
Original language | English |
---|---|
Journal | Cochrane Database of Systematic Reviews |
Issue number | 3 |
Pages (from-to) | CD005370 |
ISSN | 1361-6137 |
DOIs | |
Publication status | Published - 1 Jan 2008 |
ID: 10245834